
    
      Following recruitment subjects will have ECV measured by 51Cr-EDTA determination of GFR, with
      Brochner-Mortensen correction applied. Subjects then receive the following drugs, in a
      randomised fashion, for a period of four weeks each, with BP & ECV measurement at end of each
      period: doxazosin GITS (Cardura XL) 4 mg b.d.; frusemide 40 mg b.d.; amiloride 5 mg b.d.;
      placebo.
    
  